Literature DB >> 11749389

Comparative QSAR study of tyrosine kinase inhibitors.

A Kurup1, R Garg, C Hansch.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11749389     DOI： 10.1021/cr010154c

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  4 in total

1.  CNS Anticancer Drug Discovery and Development Conference White Paper.

Authors:  Victor A Levin; Peter J Tonge; James M Gallo; Marc R Birtwistle; Arvin C Dar; Antonio Iavarone; Patrick J Paddison; Timothy P Heffron; William F Elmquist; Jean E Lachowicz; Ted W Johnson; Forest M White; Joohee Sul; Quentin R Smith; Wang Shen; Jann N Sarkaria; Ramakrishna Samala; Patrick Y Wen; Donald A Berry; Russell C Petter
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

2.  In silico QSAR studies of anilinoquinolines as EGFR inhibitors.

Authors:  Farhan Ahmad Pasha; Muhammad Muddassar; Anil Kumar Srivastava; Seung Joo Cho
Journal:  J Mol Model       Date:  2009-07-10       Impact factor: 1.810

3.  Outliers in SAR and QSAR: 4. effects of allosteric protein-ligand interactions on the classical quantitative structure-activity relationships.

Authors:  Ki Hwan Kim
Journal:  Mol Divers       Date:  2022-02-22       Impact factor: 3.364

Review 4.  Cheminfomatic-based Drug Discovery of Human Tyrosine Kinase Inhibitors.

Authors:  Terry-Elinor Reid; Joseph M Fortunak; Anthony Wutoh; Xiang Simon Wang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.